Abbott Launches Bioresorbable Vascular Scaffold in India

by Kathy Jones on  December 20, 2012 at 8:44 PM General Health News
RSS Email Print This Page Comment bookmark
Font : A-A+

American pharmaceutical company Abbott Laboratories has launched dissolvable stents, known as Bioresorbable Vascular Scaffold, in India.
 Abbott Launches Bioresorbable Vascular Scaffold in India
Abbott Launches Bioresorbable Vascular Scaffold in India

The stent was cleared for use by the Drugs Controller General of India (DCGI) for clearing blockages in patients with clogged arteries, such as in coronary artery disease. The stent has already been launched in a number of countries, including in Europe, but is yet to be approved by the US Food and Drug Administration.

The stent had been used by doctors at Fortis Escorts Heart Institute as part of the trial to test its effectiveness and the chairman of Fortis Healthcare, Dr Ashok Seth said that it provided doctors with increased treatment options.

"With BVS, we can offer our patients a significant advancement in treating coronary artery diseases. The structure starts to resorb within one year, allowing the vessel the potential to flex, pulsate and dilate in response to normal activities such as exercise. This technology may allow blood vessels to return to a more natural state and expand long-term diagnostic and treatment options", he said.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive